UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030562
Receipt number R000034885
Scientific Title The natural history study of ambulatory patients with Duchenne muscular dystrophy
Date of disclosure of the study information 2017/12/25
Last modified on 2023/07/01 00:53:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The natural history study of ambulatory patients with Duchenne muscular dystrophy

Acronym

NH-ambulatory DMD

Scientific Title

The natural history study of ambulatory patients with Duchenne muscular dystrophy

Scientific Title:Acronym

NH-ambulatory DMD

Region

Japan


Condition

Condition

Duchenne muscular dystrophy

Classification by specialty

Neurology Pediatrics Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the natural history data of motor function in ambulatory patients with Duchenne muscular dystrophy (DMD) receiving standard care in Japan until they become non-ambulatory.

Basic objectives2

Others

Basic objectives -Others

This study is aimed to select avairable outcome measure of motor function test for drug development of DMD in the future.

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Motor function test

Key secondary outcomes

Activities of daily living (ADL)
Patient reported outcome (PRO)
Acceleration meter/activity meter
Subject demographics


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

5 years-old <=

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

1) Patients with a dystrophin abnormality proven by dystrophin gene testing or muscle pathology and a definitive diagnosis of DMD
2) Sex: male
3) Aged 5 or older (at the time of informed consent)
4) Able to rise from the floor and walk independently at baseline
5) Patients receiving oral glucocorticosteroids for at least 6 months before baseline without change in dosage or dosing regimen within 3 months and having stable symptoms
6) If participating in another clinical study, at least 6 months has passed since starting this study at baseline

Key exclusion criteria

1) Patients with clinically apparent symptoms of cardiac failure and/or respiratory failure as determined by the investigators
2) Patients continuously using a ventilator (use of non-invasive positive-pressure ventilation [NPPV] during sleep is allowed)
3) Patients with behavior abnormalities including intellectual disability, autistic tendency, and attention deficit hyperactivity disorder that, in the opinion of the investigators, could prevent to conduct the assessment of motor function
4) Other patients as determined by the investigators to be ineligible to participate in this study
5) Patients participating in another clinical trial at baseline

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Eri
Middle name
Last name Takeshita

Organization

National Center Hospital, National Center of Neurology and Psychiatry (NCNP)

Division name

Department of Child Neurology

Zip code

1878551

Address

4-1-1 Ogawahigashi-cho, Kodaira, Tokyo 187-8551, Japan

TEL

042-341-2711

Email

erit@ncnp.go.jp


Public contact

Name of contact person

1st name Mikiko
Middle name
Last name Shigemori

Organization

Muscular Dystrophy Clinical Trial Network (MDCTN)

Division name

Secretariat Office

Zip code

1878551

Address

4-1-1 Ogawahigashi-cho, Kodaira, Tokyo 187-8551, Japan

TEL

042-341-2711

Homepage URL


Email

shigemori@ncnp.go.jp


Sponsor or person

Institute

National Center of Neurology and Psychiatry (NCNP)

Institute

Department

Personal name



Funding Source

Organization

National Center of Neurology and Psychiatry (NCNP)

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)

pharmaceutical company


IRB Contact (For public release)

Organization

National Center of Neurology and Psychiatry (NCNP)

Address

4-1-1 Ogawahigashi-cho, Kodaira, Tokyo 187-8551, Japan

Tel

042-341-2711

Email

ml_rinrijimu@ncnp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立病院機構鈴鹿病院(三重県)
国立病院機構八雲病院(北海道)
熊本大学医学部附属病院(熊本県)
国立病院機構刀根山病院(大阪府)
国立病院機構宇多野病院(京都府)
国立病院機構東埼玉病院(埼玉県)
国立病院機構大牟田病院(福岡県)
国立病院機構医王病院(石川県)
国立病院機構長良医療センター(岐阜県)
岐阜大学医学部附属病院(岐阜県)
信州大学医学部附属病院(長野県)
東京女子医科大学病院(東京都)
兵庫医科大学病院(兵庫県)
長崎大学病院(長崎県)
名古屋市立大学病院(愛知県)
国立精神・神経医療研究センター病院(東京都)


Other administrative information

Date of disclosure of the study information

2017 Year 12 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

33

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2017 Year 09 Month 25 Day

Date of IRB

2017 Year 10 Month 06 Day

Anticipated trial start date

2018 Year 01 Month 25 Day

Last follow-up date

2025 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Prospective observational study now underway.


Management information

Registered date

2017 Year 12 Month 25 Day

Last modified on

2023 Year 07 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034885


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name